Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00ZRS
|
|||
| Former ID |
DIB002433
|
|||
| Drug Name |
TARP peptide vaccines
|
|||
| Synonyms |
TARP peptide vaccines (prostate cancer); TARP peptide vaccines (prostate cancer), NCI; Epiptope-enhanced TARP peptide (prostate cancer), NCI; TARP-27-35 peptide vaccine (prostate cancer), NCI; TARP-29-37-9V peptide vaccine (prostate cancer), NCI
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1 | [1] | |
| Company |
National Cancer Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02362464) Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.